United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 1995_register executive 2010-09-25 article Title 21 Part 1307 21 CFR Part 1307 Title 21 Part 1309 21 CFR Part 1309 Title 21 Part 1310 21 CFR Part 1310 Title 21 Part 1313 21 CFR Part 1313 Title 21 Part 1316 21 CFR Part 1316 Title 28 Part 16.7 28 CFR Part 16.7 RIN 1117-AA23 ; Federal Register Vol. 60, Issue RULE 95-14978 Policy Section, Office of Diversion Control, Drug Enforcement Interim Rule notice entitled Provisional Exemption From Registration Formal comments that were received in response to the NPRM regarding Regulatory Flexibility and Small Business Impact DCDCA to eliminate sales to clandestine laboratories. DCDCA remains uncertain. List I chemicals for internal use, with no subsequent distribution or However, such an action would negate the purpose of the DCDCA by The requirements were withdrawn by notice published in the Federal However, in other areas, DEA has been able to take additional steps in Public Comments Registration These commentors questioned how the requirement for separate Further, the products referenced by the commentors are chemical Under this review, any major change in the registration population I chemical to obtain a registration and requires that DEA determine if Brokers and Traders Security Provisions I chemicals, such as ephedrine, thus increasing the burden required to List I chemicals makes it difficult to employ comprehensive screen However, registrants must employ safeguards to prevent List I chemicals The section does not prohibit any person from purchasing the product or Trafficking Act, that exports of listed chemicals might be rejected or One objected that the summary reports of imports required by Section Exports Administrator to withdraw the waiver of the advance notice requirement The comment also questioned whether other countries have agreed to It is possible that the waiver of the advance notice requirement for However, DEA would be required to publish a notice in the Federal Register regarding the withdrawal of the waiver and provide an United Nations Convention Against Illicit Traffic in Narcotic Drugs and Exporters should understand the nature of their legitimate transactions Definition of Therapeutically Insignificant A person requesting a determination from the Administrator that a Contents of Records and Reports Further, the pharmacist counseling provision would create a third class Miscellaneous DEA. In the HTS numbering system there are multiple chemicals that are Chemical Code Numbers. List II chemicals. Under these acts, the only exceptions to the However, preparations of the ephedra plant, such as extracts and United States. Register for past notices of suspension of controlled substance List I chemical. DEA will mail delinquency notices to expired DEA has proposed steps to lessen the impact on retail distributors and With respect to the second question, DEA has taken steps to limit the The amounts of product distributed per transaction are generally small Investigations will be significantly more complex and time consuming Protection of Confidential Business Information With respect to the chemical program, the release of CBI that is Justice procedures establish that if a FOIA request is received for List of Subjects Security measures, List I and List II chemicals. Research, Seizures and forfeitures. DEA No. 112F 4410-09-M 95-14978 Final rule.

This final rule establishes regulations to implement the Domestic Chemical Diversion Control Act of 1993 (DCDCA or Act). These regulations provide additional safeguards to prevent and detect the diversion of listed chemicals by illicit drug manufacturers.

August 21, 1995. Persons seeking registration must apply on or before October 5, 1995 in order to continue their business pending final action by DEA on their application. G. Thomas Gitchel, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, D.C. 20537, Telephone (202) 307-7297. Vol. 60, no. 120 Office of the Federal Register, National Archives and Records Administration 1995-06-22 continuing daily deposited born digital 164 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-1995-06-22 P0b002ee180a8adcd 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr22jn95 https://www.govinfo.gov/app/details/FR-1995-06-22 https://www.govinfo.gov/content/pkg/FR-1995-06-22/pdf/FR-1995-06-22.pdf fdlp 32421 32575 DGPO 2010-09-25 2023-05-07 FR-1995-06-22 machine generated eng FR FR-1995-06-22 60 120